Search
Close this search box.

Current Edition

Current Features

Living and Breathing: The Inhalation Industry’s Green Transition

Sustainability is multi-faceted. Beyond direct environmental impacts such as carbon emissions from manufacturing, a company’s sustainable practices should also account for indirect impacts across the ...
Continue Reading →
Current Features

Achieving Sustainability in Pharma Manufacturing

The environmental impact of the pharmaceutical industry is hard to quantify, but it has been suggested Pharma may be responsible for 300 million tons of ...
Continue Reading →
Current Features

Staying Ahead of Green Propellant Regulations in pMDIs Navigating the transition to green propellants, while maintaining performance and usability

The next few years will see substantial changes for pressurised metered-dose inhalers (pMDIs). As a result of emerging regulations such as the European Union’s F-Gas ...
Continue Reading →
Current Features

The Next Frontier for Inhaled Therapies: Low Global Warming Propellants and the Future of pMDI Development

The pharmaceutical inhalation industry stands at a pivotal crossroads. After decades of relative stability following the phase-out of CFCs in the 1990s, a second major ...
Continue Reading →
Current Features

Study Designs and Digital Technologies for Sustainable Clinical Trials

The clinical trial industry is essential for ensuring the safety and efficacy of new medicines; however, it is also a significant contributor of greenhouse gas ...
Continue Reading →

Current Edition

Current Features

Current Features

Current Features

Achieving Sustainability in Pharma Manufacturing

The environmental impact of the pharmaceutical industry is hard to quantify, but it has been suggested Pharma may be responsible for 300 million tons of plastic waste each ...
Read More →
Current Features

Staying Ahead of Green Propellant Regulations in pMDIs Navigating the transition to green propellants, while maintaining performance and usability

The next few years will see substantial changes for pressurised metered-dose inhalers (pMDIs). As a result of emerging regulations such as the European Union’s F-Gas legislation and the ...
Read More →
Current Features

The Next Frontier for Inhaled Therapies: Low Global Warming Propellants and the Future of pMDI Development

The pharmaceutical inhalation industry stands at a pivotal crossroads. After decades of relative stability following the phase-out of CFCs in the 1990s, a second major transition is underway, ...
Read More →
Current Features

Study Designs and Digital Technologies for Sustainable Clinical Trials

The clinical trial industry is essential for ensuring the safety and efficacy of new medicines; however, it is also a significant contributor of greenhouse gas emissions. The Sustainable ...
Read More →
Current Features

Rethinking Growth Promoters Through the Lens of Green Chemistry

As veterinary medicine continues to evolve, so too do the expectations around how treatments are developed and produced. In recent years, there has been a significant shift towards ...
Read More →
Current Features

Cold Chain in the Context of Global Warming

Global distribution of life-saving pharmaceuticals is incredibly complex, with several different components from warehouse to final delivery. At each stage, providers must make sure strict temperature requirements are ...
Read More →

Advertisement

Company Profiles

OWEN MUMFORD PHARMACEUTICAL SERVICES

With more than 70 years’ experience in medical devices, Owen Mumford Pharmaceutical Services is a division of Owen Mumford, with the Head Office located in ...
Read More →